Complete pathologic response of HER2-positive breast cancer liver metastasis with dual Anti-HER2 antagonism

被引：0
|
作者：
Hans F Schoellhammer
Felicia Hsu
Courtney Vito
Peiguo Chu
Jinha Park
James Waisman
Joseph Kim
机构：
[1] City of Hope Comprehensive Cancer Center,Division of Surgical Oncology, Department of Surgery
[2] City of Hope Comprehensive Cancer Center,Department of Pathology
[3] City of Hope Comprehensive Cancer Center,Department of Radiology
[4] City of Hope Comprehensive Cancer Center,Department of Medical Oncology and Experimental Therapeutics Research
来源：
BMC Cancer | / 14卷
关键词：
HER2-positive breast cancer; Targeted therapy; Breast cancer liver metastases; Trastuzumab; Pertuzumab; Complete pathologic response;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Complete pathologic response of HER2-positive breast cancer liver metastasis with dual Anti-HER2 antagonism
    Schoellhammer, Hans F.
    Hsu, Felicia
    Vito, Courtney
    Chu, Peiguo
    Park, Jinha
    Waisman, James
    Kim, Joseph
    BMC CANCER, 2014, 14
  • [2] Pathologic complete response to neoadjuvant anti-HER2 therapy is associated with HER2 immunohistochemistry score in HER2-positive early breast cancer
    Chen, Hai-Long
    Chen, Qiang
    Deng, Yong-Chuan
    MEDICINE, 2021, 100 (44)
  • [3] Pathologic complete response (pCR) and prognosis following neoadjuvant chemotherapy plus anti-HER2 therapy of HER2-positive early breast cancer (EBC)
    Loibl, Sibylle
    Untch, Michael
    Buyse, Marc
    Robidoux, Andre
    Gianni, Luca
    Schneeweiss, Andreas
    Conte, Pierfranco
    Piccart, Martine
    Bonnefoi, Herve
    Jackisch, Christian
    Nekljudova, Valentina
    Costantino, Joseph
    Valagussa, Pinuccia
    Neate, Colin
    Gelber, Richard
    Poncet, Coralie
    Squifflet, Pierre
    Saad, Everardo
    Heinzmann, Dominik
    Denkert, Carsten
    Geyer, Charles E., Jr.
    Cortes, Javier
    Guarneri, Valentina
    de Azambuja, Evandro
    Cameron, David
    Ismael, Gustavo
    von Minckwitz, Gunter
    Wolmark, Norman
    Cortazar, Patricia
    CANCER RESEARCH, 2020, 80 (04)
  • [4] Comprehensive assessment of cancer stem cell like cells in prediction of pathologic complete response to preoperative dual anti-HER2 therapy for HER2-positive primary breast cancer.
    Fernandez, Jose Rodrigo Espinosa
    Yamauchi, Teruo
    Imamura, Chiyo K.
    Yamauchi, Hideko
    Jinno, Hiromitsu
    Takahashi, Maiko
    Kitagawa, Yuko
    Nakamura, Seigo
    Lim, Bora
    Krishnamurthy, Savitri
    Reuben, James M.
    Liu, Diane D.
    Tripathy, Debu
    Chen, Helen X.
    Takebe, Naoko
    Saya, Hideyuki
    Ueno, Naoto T.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [5] In situ HER2 RNA expression as a predictor of pathologic complete response of HER2-positive breast cancer patients receiving neoadjuvant chemotherapy and anti-HER2 targeted treatment
    Lien, Huang-Chun
    Lo, Chiao
    Lee, Yi-Hsuang
    Lin, Po-Hang
    Wang, Ming-Yang
    Kuo, Wen-Hung
    Tsai, Li-Wei
    Lu, Yen-Shen
    Hu, Hsiang-Wei
    Li, Yu-Chia
    Huang, Chiun-Sheng
    BREAST CANCER RESEARCH, 2024, 26 (01)
  • [6] Determining the Factors Predicting the Response to Anti-HER2 Therapy in HER2-Positive Breast Cancer Patients
    You, Ji Young
    Park, Kyoung Hwa
    Lee, Eun Sook
    Kwon, Youngmee
    Kim, Kyoung Tae
    Nam, Seungyoon
    Kim, Dong Hee
    Bae, Jeoung Won
    CANCER CONTROL, 2023, 30
  • [7] Determining the Factors Predicting the Response to Anti-HER2 Therapy in HER2-Positive Breast Cancer Patients
    You, Ji Young
    Park, Kyoung Hwa
    Lee, Eun Sook
    Kwon, Youngmee
    Kim, Kyoung Tae
    Nam, Seungyoon
    Kim, Dong Hee
    Bae, Jeoung Won
    CANCER CONTROL, 2022, 29
  • [8] HER2-positive breast cancer: From trastuzumab to innovatory anti-HER2 strategies
    Whenham, Nicolas
    D'Hondt, Veronique
    Piccart, Martine J.
    CLINICAL BREAST CANCER, 2008, 8 (01) : 38 - 49
  • [9] Cardiac Safety of Dual Anti-HER2 Therapy in the Neoadjuvant Setting for Treatment of HER2-Positive Breast Cancer
    Yu, Anthony F.
    Singh, Jasmeet C.
    Wang, Rui
    Liu, Jennifer E.
    Eaton, Anne
    Oeffinger, Kevin C.
    Steingart, Richard M.
    Hudis, Clifford A.
    Dang, Chau T.
    ONCOLOGIST, 2017, 22 (06): : 642 - 647
  • [10] Differential response of HER2-positive breast cancer to anti-HER2 therapy based on HER2 protein expression level
    Atallah, N. M.
    Alsaleem, M.
    Toss, M. S.
    Mongan, N. P.
    Rakha, E.
    BRITISH JOURNAL OF CANCER, 2023, 129 (10) : 1692 - 1705
12345